Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03242005

The PSIQS Study - User Experience With Pro-Set

The PSIQS Study - User Experience With the Pro-Set Over Intended Wear of 3 Days With New Instructions and Requirement to be Inserted With the Quick-Serter

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Becton, Dickinson and Company · Industry
Sex
All
Age
13 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Open label, randomized 2-period cross-over study comparing two continuous subcutaneous insulin infusion sets ; MiniMed® Pro-set® with BD FlowSmart™ technology and MiniMed® Quick-set®

Conditions

Interventions

TypeNameDescription
DEVICEMiniMed® Pro-set®Utilization of the MiniMed® Pro-set® to administer the subject's current insulin therapy.
DEVICEMiniMed® Quick-set®Utilization of the MiniMed® Quick-set® to administer the subject's current insulin therapy.

Timeline

Start date
2017-09-01
Primary completion
2017-12-01
Completion
2018-02-01
First posted
2017-08-08
Last updated
2017-09-14

Regulatory

Source: ClinicalTrials.gov record NCT03242005. Inclusion in this directory is not an endorsement.